Rapamycin is a medical drug used to prevent organ rejection after a transplant. It is commonly known as Rapamune. It is also used in the treatment of cancer and a rare lung disease. It was first used as an anti-fungal agent. However, further research showed that the drug had immunosuppressive and antiproliferative properties. Mikhail Blagosklonny is known for his role in Roswell Park Cancer Institute. He has conducted a wide range of research into cancer therapies. Recently, he came with a theory that Rapamycin can be used to prolong the lifespan of a human being. Rapamycin has been found to possess a lot of healing properties. It has, therefore, been termed as one of the best medicine in the medical industry.
Rapamycin has immunosuppressive features that enable it to find use in organ transplant. It is a principle reaction of the human body to reject a new organ. As a result, Rapamycin is used as an anti-rejection drug. Most of the medications used as calcineurin inhibitors are toxic to the kidneys. However, Rapamycin has low levels of toxicity making it the best medicine. The drug is used to treat LAM, a disease affecting women of the childbearing age. It is also used as a coronary stent coating. What the drug does is to prevent the occurrence of restenosis after balloon angioplasty. Using Rapamycin eliminates the need to repeat the procedure.
Another crucial role of Rapamycin is its use in the treatment of cancer. It enhances the immune system against cancerous cells. Additionally, it promotes tumor regression. The drug is also used in the treatment of TSC. Discontinuation of the drug showed an additional tumor growth. It has also found use in the treatment of Alzheimer disease and muscular dystrophy. There is also an ongoing research that seeks to identify its role in the treatment of systemic lupus erythematosus.
Mikhail is also known for his philanthropic activities. In a statement, he says that much of his work goes towards ensuring that people get the best possible treatment despite their economic state. Blagosklonny focuses on the aging process and its relation to cancer. He uses his knowledge to mentor students in oncology. As a professor, he desires to teach and mentor students who will take over in the oncology field.
Most of his research areas and topics have received special attention from experts in the medical field. His core goal is to come up with a drug or a method of curing cancer while eliminating the excruciating pain that patients go through. He hopes to develop mechanisms through which cancerous cells can be removed without harming the healthy cells. Additionally, his research focuses on developing a cure that’ll be accessible to all patients despite their financial power.
Mikhail Blagosklonny has made tremendous progress in the oncology field. Additionally, he hopes that there will be people bold enough to continue with his work. It is also his belief that cancer treatment will no longer be a luxury for the rich. Instead, breakthroughs will have made the procedure cost-effective.